Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TANC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | RP11-400G3.5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | PDK2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | SPINT4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | SPTA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | RASGRP3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | LSP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | EBLN2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | SORCS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | ETV4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |